Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dickhoff

Showing results (211-220 of 231) with videos related to

Pageof 24
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 1, 2025
Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer groupE Xenophontos, N Giaj Levra, V Durieux, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2021
Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancerMerle I Ronden, Idris Bahce, Sayed M S Hashemi, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary HypertensionXue D Manz, Robert Szulcek, Xiaoke Pan, et al.
Journal for Immunotherapy of Cancer|September 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE studyIdris Bahce, Chris Dickhoff, Famke L Schneiders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2026
Outcomes of stereotactic ablative radiotherapy or surgery for early-stage lung cancer in patients with interstitial lung diseaseMathijs L Tomassen, Suzan F M Nijman, Esther J Nossent, et al.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2024
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancerIlias Houda, Idris Bahce, Chris Dickhoff, et al.
Cardiovascular Research|July 23, 2018
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertensionNina Rol, Michiel A de Raaf, Xiaoqing Q Sun, et al.
The Lancet. Respiratory Medicine|April 19, 2024
Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trialKirsten A Kalverda, Maarten K Ninaber, Lizzy Wijmans, et al.
JTO Clinical and Research Reports|September 30, 2021
The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter AnalysisMerle I Ronden, Idris Bahce, Niels J M Claessens, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 1, 2024
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark studyMyrthe Y C van der Heide, Tom E Verstraelen, Freyja H M van Lint, et al.
Pageof 24

Showing results (211-220 of 231) with videos related to

Sort By:
Pageof 24
Lung Cancer (Amsterdam, Netherlands)|August 1, 2025
Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer groupE Xenophontos, N Giaj Levra, V Durieux, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2021
Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancerMerle I Ronden, Idris Bahce, Sayed M S Hashemi, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary HypertensionXue D Manz, Robert Szulcek, Xiaoke Pan, et al.
Journal for Immunotherapy of Cancer|September 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE studyIdris Bahce, Chris Dickhoff, Famke L Schneiders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2026
Outcomes of stereotactic ablative radiotherapy or surgery for early-stage lung cancer in patients with interstitial lung diseaseMathijs L Tomassen, Suzan F M Nijman, Esther J Nossent, et al.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2024
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancerIlias Houda, Idris Bahce, Chris Dickhoff, et al.
Cardiovascular Research|July 23, 2018
Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertensionNina Rol, Michiel A de Raaf, Xiaoqing Q Sun, et al.
The Lancet. Respiratory Medicine|April 19, 2024
Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trialKirsten A Kalverda, Maarten K Ninaber, Lizzy Wijmans, et al.
JTO Clinical and Research Reports|September 30, 2021
The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter AnalysisMerle I Ronden, Idris Bahce, Niels J M Claessens, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 1, 2024
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark studyMyrthe Y C van der Heide, Tom E Verstraelen, Freyja H M van Lint, et al.
Pageof 24